visiongain Logo.png
Viral Vectors and Plasmid DNA Manufacturing market is projected to grow at a CAGR of 18.09% by 2032: Visiongain Reports Ltd
December 23, 2022 06:00 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled Viral Vectors and Plasmid DNA Manufacturing 2022-2032. It includes profiles of Viral Vectors and Plasmid DNA Manufacturing and Forecasts Market...
visiongain Logo.png
Gene therapy R&D market is projected to grow at a CAGR of 30.1% by 2032: Visiongain Reports Ltd
November 29, 2022 12:29 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled Gene Therapy R&D 2022-2032. It includes profiles of Gene Therapy R&D and Forecasts Market Segment by Disease {Cancer, Rare Diseases (Oncologic,...
visiongain Logo.png
Viral Vectors and Plasmid DNA Manufacturing market is projected to grow at a CAGR of 18.09% by 2032: Visiongain Reports Ltd
October 27, 2022 07:51 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled Viral Vectors and Plasmid DNA Manufacturing 2022-2032. It includes profiles of Viral Vectors and Plasmid DNA Manufacturing and Forecasts Market Segment...
visiongain Logo.png
Gene therapy R&D market is projected to grow at a CAGR of 30.1% by 2032: Visiongain Reports Ltd
September 19, 2022 06:00 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled Gene Therapy R&D 2022-2032. It includes profiles of Gene Therapy R&D and Forecasts Market Segment by Disease {Cancer, Rare Diseases (Oncologic,...
visiongain Logo.png
Global Gene Therapy R&D Market Worth US$ 22,685.70 million by 2031: Visiongain Reports Ltd
September 05, 2022 07:08 ET | Visiongain Reports Ltd
Global Gene Therapy R&D Market Forecast 2021-2031: - Market Segment by Disease {Cancer, Rare Diseases (Oncologic, Non-Oncologic), Cardiovascular Diseases, Ophthalmic Diseases, Hematology,...
visiongain Logo.png
Global Gene Therapy R&D Market Worth US$ 22,685.70 Million by 2031: Visiongain Research Inc.
June 29, 2021 11:36 ET | Visiongain Ltd
Global Gene Therapy R&D Market Forecast 2021-2031: - Market Segment by Disease {Cancer, Rare Diseases (Oncologic, Non-Oncologic), Cardiovascular Diseases, Ophthalmic Diseases, Hematology,...